Novel Treatment of Emotional Dysfunction in Post Traumatic Stress Disorder (PTSD)
Novel Treatment of Emotional Dysfunction in PTSD
Sponsor: The University of Texas at Dallas
This NA trial investigates Post Traumatic Stress Disorder and is currently completed. The University of Texas at Dallas leads this study, which shows 10 recorded versions since 2011 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Feb 2024 — Jul 2024 [monthly]
Completed NA
-
Dec 2023 — Feb 2024 [monthly]
Completed NA
-
Jan 2021 — Dec 2023 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Oct 2020 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Oct 2020 [monthly]
Completed NA
-
Jul 2017 — Jun 2018 [monthly]
Completed NA
Status: Enrolling By Invitation → Completed
-
Feb 2017 — Jul 2017 [monthly]
Enrolling By Invitation NA
-
Jan 2017 — Feb 2017 [monthly]
Enrolling By Invitation NA
First recorded
Jul 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The University of Texas at Dallas
- United States Department of Defense
- University of Texas Southwestern Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .